Status:

COMPLETED

Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration

Lead Sponsor:

University of Zurich

Conditions:

Rhinoconjunctivitis

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

Primary Objective Comparison of the inhibition of the allergic response assessed by nasal provocation test after epicutanous pollen allergen administration and placebo epicutaneous administration. Se...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Written informed consent
  • History of grass pollen allergic rhinitis
  • Male and female between 18 years to 65 years
  • Positive skin prick test to grass pollen
  • Positive nasal provocation test
  • Exclusion criteria:
  • Atopic eczema in history or permanent
  • Perennial allergic rhinitis
  • Symptoms of infectious disease with rhinitis in between the last 2 weeks
  • Surgical intervention in between the last 30 days
  • Pregnancy or nursing
  • History of HIV or AIDS
  • Mastocytosis (cutaneous or systemic)
  • Significant cardiovascular disease
  • Hypertension (blood pressure \> 160 / 95)
  • Significant pulmonary, renal and/or hepatic disease
  • Significant hematological disorder
  • Moderate or severe asthma
  • History of malignancy
  • History of neurological or psychatric disease
  • Autoimmune disease
  • Antihistamines with longed half-lives in the last week
  • Systemic or topical steroids for 5 days
  • Active infectious disease
  • Contraindicated medications: - immunosuppressive agents
  • Betablockers
  • ACE-inhibitors
  • Tricyclic antidepressants
  • Daily use of Beta-agonists or steroid inhalers
  • Participation in another clinical trial /study in between the last 60 days
  • Participation in another clinical trial / study at the moment

Exclusion

    Key Trial Info

    Start Date :

    December 1 2005

    Trial Type :

    INTERVENTIONAL

    End Date :

    November 1 2006

    Estimated Enrollment :

    35 Patients enrolled

    Trial Details

    Trial ID

    NCT00457444

    Start Date

    December 1 2005

    End Date

    November 1 2006

    Last Update

    April 6 2007

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Zurich

    Zurich, Switzerland